The Dead GiveawayFurther testing. It is a good thing. If something does not work you do not keep wasting time and money testing it. Think about it! They are obviously seeing positive results to continue with testing. They are doing testing with the University Health Network (UHN), the largest research organization in the country.
If this device can inactivate Zika it is obviously a huge thing so they must be absolutely sure that it works and test it in every way possible. They are taking their time with this, as they should. The only people freaking out over a timeline are impatient investors.
Also, as has been stated numerous times, if testing has not been going well why in the world would insiders (people who actually have first hand knowledge of the testing!) continue to purchase shares after the private placement?
This is from as recent as August 17:
"Jenex would like to report that Mr. Rob Fia, Chief Executive Officer of the Company, John Gamble, a director of the Company, and other close associates thereof have purchased an aggregate of 2,347,000 common shares under escrow of the Company"